In unstable angina/NSTEMI, the primary benefits of<unk>  blockers are due to the inhibition of<unk> -1 adrenergic receptors, which results in a decrease in cardiac work and myocardial oxygen demand.  Slowing of the heart rate also has a favorable effect, acting not only to reduce myocardial oxygen demand (MVO2) but also to increase the duration of diastole and diastolic pressure-time, a determinant of forward coronary flow and collateral flow.
Unstable angina / non ST elevation myocardial infarction beta blockers
Unstable angina / non ST elevation myocardial infarction calcium channel blockers
Unstable angina / non ST elevation myocardial infarction aspirin therapy
Unstable angina / non ST elevation myocardial infarction nitrate therapy
Unstable angina / non ST elevation myocardial infarction thienopyridines
Unstable angina / non ST elevation myocardial infarction analgesics
ST elevation myocardial infarction primary percutaneous coronary intervention
Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines depression